Oncolytic viruses targeting tumor stem cells.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 24753541.
- Also identified by DOI 10.1158/0008-5472.CAN-14-0290.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A workshop "Targeting Oncolytic Viruses to Tumor Stem Cells," organized by the Division of Cancer Biology, NCI, NIH, was held on September 6, 2013 in Rockville, MD. Seventeen invited experts presented an overview of their current research in this area and discussed the state of current research on the use of oncolytic viruses targeted to stem cells as a potential cancer therapy. The goal was to evaluate the evidence that this approach might increase the efficacy of oncolytic virus therapy and to identify gaps in knowledge that have retarded progress in this area.
Medical subject headings
- Molecular Targeted Therapy
- Neoplasms
- Neoplastic Stem Cells
- Oncolytic Virotherapy
- Oncolytic Viruses